SUN-754 Unveiling a Rare Case of Pediatric Hypophosphatasia: Discovery of a Novel ALPL Gene Variant

Abstract Disclosure: M.I. Chiamolera: Consultant of Fleury Group. G.M. Spolador: Fleury Group. J.V. Lima: Consultant of Fleury Group. P. Saddi-Rosa: Fleury Group. R.M. Biscolla: Consultant of Fleury Group. S.S. Maeda: None. Background: Hypophosphatasia (HPP) is a rare disorder caused by variants in the ALPL gene, that encodes the tissue-nonspecific alkaline phosphatase protein (TNSALP), an enzyme involved in the dephosphorylation of a wide range of substrates. Mild HPP is caused by a functional loss of one of the copies of the ALPL gene, leading to autosomal dominant inheritance. Clinical Case: A 8-year-old male patient referred for evaluation of growth delay and low body weight. Initial tests were consistent with HPP: low alkaline phosphatase (ALP) level of 88 U/L (reference range: 142-355 U/L), elevated B6 levels of 75.7 ng/mL (reference range: 8.7 – 27.2 ng/mL). However, the patient showed no signs of rickets. Cranial tomography and skull radiographs suggest a beaten copper appearance. The patient´s father, paternal grandmother and paternal aunt also presented low ALP levels, and the paternal aunt also had short stature. Notably, none of the family members exhibited dental loss. Given the clinical presentation and family history, a genetic panel was requested for further investigation into potential bone fragility disorders. Next-generation sequencing (NGS) identified a novel probably pathogenic variant in the ALPL gene (c.944_946del: p.Val315del) in heterozygous form. Interestingly, the same variant was found in the patient´s father, grandmother and aunt suggesting a possible autosomal dominant inheritance pattern. Conclusion: Further clinical follow-up, including radiographic and biochemical monitoring, along with genetic counseling, is warranted. This case highlights the importance of considering HPP in the differential diagnosis of pediatric patients with growth delay, low stature, and low alkaline phosphatase levels, even in the absence of classic features such as rickets or dental abnormalities. Presentation: Sunday, July 13, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.704
Primary Topic
Alkaline Phosphatase Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SUN-754 Unveiling a Rare Case of Pediatric Hypophosphatasia: Discovery of a Novel ALPL Gene Variant

Gustavo Marquezani Spolador, José Viana Lima, Sérgio Setsuo Maeda, Maria Izabel Chiamolera et al.
Journal of the Endocrine Society
Alkaline Phosphatase Research Studies
article

SUN-754 Unveiling a Rare Case of Pediatric Hypophosphatasia: Discovery of a Novel ALPL Gene Variant

Gustavo Marquezani Spolador, José Viana Lima, Sérgio Setsuo Maeda, Maria Izabel Chiamolera, Rosa Paula M. Biscolla, Pedro Saddi-Rosa
article en

Abstract

Abstract Disclosure: M.I. Chiamolera: Consultant of Fleury Group. G.M. Spolador: Fleury Group. J.V. Lima: Consultant of Fleury Group. P. Saddi-Rosa: Fleury Group. R.M. Biscolla: Consultant of Fleury Group. S.S. Maeda: None. Background: Hypophosphatasia (HPP) is a rare disorder caused by variants in the ALPL gene, that encodes the tissue-nonspecific alkaline phosphatase protein (TNSALP), an enzyme involved in the dephosphorylation of a wide range of substrates. Mild HPP is caused by a functional loss of one of the copies of the ALPL gene, leading to autosomal dominant inheritance. Clinical Case: A 8-year-old male patient referred for evaluation of growth delay and low body weight. Initial tests were consistent with HPP: low alkaline phosphatase (ALP) level of 88 U/L (reference range: 142-355 U/L), elevated B6 levels of 75.7 ng/mL (reference range: 8.7 – 27.2 ng/mL). However, the patient showed no signs of rickets. Cranial tomography and skull radiographs suggest a beaten copper appearance. The patient´s father, paternal grandmother and paternal aunt also presented low ALP levels, and the paternal aunt also had short stature. Notably, none of the family members exhibited dental loss. Given the clinical presentation and family history, a genetic panel was requested for further investigation into potential bone fragility disorders. Next-generation sequencing (NGS) identified a novel probably pathogenic variant in the ALPL gene (c.944_946del: p.Val315del) in heterozygous form. Interestingly, the same variant was found in the patient´s father, grandmother and aunt suggesting a possible autosomal dominant inheritance pattern. Conclusion: Further clinical follow-up, including radiographic and biochemical monitoring, along with genetic counseling, is warranted. This case highlights the importance of considering HPP in the differential diagnosis of pediatric patients with growth delay, low stature, and low alkaline phosphatase levels, even in the absence of classic features such as rickets or dental abnormalities. Presentation: Sunday, July 13, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR), Fleury S.A. (Brazil) (BR), Universidade Federal de São Paulo (BR)
Openalex Percentile: Top 59%
Alkaline Phosphatase Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.